CIS Oncology Overview
- Year Founded
-
1989
- Status
-
Acquired/Merged
- Employees
-
18
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
1
CIS Oncology General Information
Description
Provider of automated chemotherapy prescribing based in Belfast, United Kingdom. The company's services include adult oncology and hematology prescribing, pediatric oncology prescribing, scheduling for treatment and ad-hoc interventions, medication management, and other related services, helping healthcare professionals to electronically prescribe, prepare, and administer chemotherapy safely and with certainty.
Contact Information
Website
www.cis-healthcare.com(Operating Subsidiary)
Corporate Office
- The Innovation Centre
- Queens Road, Queens Island
- Belfast BT3 9DT
- Northern Ireland, United Kingdom
Corporate Office
- The Innovation Centre
- Queens Road, Queens Island
- Belfast BT3 9DT
- Northern Ireland, United Kingdom
CIS Oncology Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
CIS Oncology Signals
CIS Oncology FAQs
-
When was CIS Oncology founded?
CIS Oncology was founded in 1989.
-
Where is CIS Oncology headquartered?
CIS Oncology is headquartered in Belfast, United Kingdom.
-
What is the size of CIS Oncology?
CIS Oncology has 18 total employees.
-
What industry is CIS Oncology in?
CIS Oncology’s primary industry is Practice Management (Healthcare).
-
Is CIS Oncology a private or public company?
CIS Oncology is a Private company.
-
What is CIS Oncology’s current revenue?
The current revenue for CIS Oncology is .
-
When was CIS Oncology acquired?
CIS Oncology was acquired on 20-Oct-2024.
-
Who acquired CIS Oncology?
CIS Oncology was acquired by System C Healthcare.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process